Jens Eckstein

Directeur Général chez Samsara Therapeutics, Inc. Fortune : 30 081 $ au 31/08/2026

Profil

Jens W.
Eckstein currently works at Samsara Therapeutics, Inc., as Chairman & Chief Executive Officer, Aeovian Pharmaceuticals, Inc., as Director, Cleara Biotech BV, as Director from 2022, HAYA Therapeutics SA, as Director, and Apollo Ventures Holding GmbH, as Managing Partner from 2019.
Dr. Eckstein also formerly worked at SelectX Pharmaceuticals, Inc., as President & Chief Executive Officer in 2011, PPD Dermatology LLC, as Director, Concert Pharmaceuticals, Inc., as Director, Rapid Micro Biosystems, Inc., as Director, Alios BioPharma, Inc., as Director, Anchor Therapeutics, Inc., as Director, Enanta Pharmaceuticals, Inc., as Director, Thrasos Therapeutics, Inc., as Director, Biohealth Innovation, Inc., as Director, Action Potential Venture Capital, as Director from 2013 to 2019, ZappRx, Inc., as Director, Gladius Pharmaceuticals Corp., as Director, Decibel Therapeutics, Inc., as Director, Palleon Pharmaceuticals, Inc., as Director, Imugene Ltd., as Independent Non-Executive Director from 2019 to 2024, Sirtris Pharmaceuticals, Inc., as Advisor, GSK Equity Investments Ltd., as President, GPC Biotech, Inc., as Principal from 1993 to 2003, and TVM Capital Corp., as Venture Partner.
Dr. Eckstein received his doctorate degree from Harvard University and doctorate degree from Universität Konstanz.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
IMUGENE LTD 0,12 %	30/06/2025	617 297 ( 0,12 % )	30 081 $	31/08/2026

Postes actifs de Jens Eckstein

Sociétés	Poste	Début
Samsara Therapeutics, Inc.	Directeur Général	-
Aeovian Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-
Cleara Biotech BV	Directeur/Membre du Conseil	27/09/2022
Apollo Ventures Holding GmbH	Private Equity Investor	01/06/2019
HAYA Therapeutics SA	Directeur/Membre du Conseil	-

Anciens postes connus de Jens Eckstein

Sociétés	Poste	Fin
IMUGENE LIMITED	Directeur/Membre du Conseil	14/11/2024
GSK Equity Investments Ltd.	President	01/07/2019
Action Potential Venture Capital	Directeur/Membre du Conseil	01/05/2019
Gladius Pharmaceuticals Corp.	Directeur/Membre du Conseil	01/04/2019
░░░ ░░░░░░░ ░░░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	-